Riverwater Partners’s LeMaitre Vascular LMAT Stock Holding History

Riverwater Partners’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$2.43M	Buy	22,271 +908	+4%	+$86.5K	0.81%	40
2025 Q4	$1.73M	Buy	21,363 +362	+2%	+$31.2K	0.67%	47
2025 Q3	$1.84M	Sell	21,001 -8,174	-28%	-$730K	0.76%	38
2025 Q2	$2.42M	Sell	29,175 -38	-0.1%	-$3.18K	1.14%	20
2025 Q1	$2.45M	Sell	29,213 -1,563	-5%	-$145K	1.26%	16
2024 Q4	$2.84M	Sell	30,776 -925	-3%	-$89K	1.38%	12
2024 Q3	$2.89M	Buy	31,701 +24,401	+334%	+$2.11M	1.43%	11
2024 Q2	$601K	Sell	7,300 -804	-10%	-$59.1K	0.45%	63
2024 Q1	$538K	Sell	8,104 -112	-1%	-$6.91K	0.4%	72
2023 Q4	$466K	Buy	8,216 +198	+2%	+$10.4K	0.37%	77
2023 Q3	$437K	Buy	8,018 +3,564	+80%	+$211K	0.4%	79
2023 Q2	$300K	Hold	4,454	–	–	0.27%	127
2023 Q1	$229K	Buy	4,454 +3	+0.1%	+$146	0.21%	159
2022 Q4	$205K	Buy	4,451 +86	+2%	+$4.03K	0.17%	187
2022 Q3	$221K	Sell	4,365 -2,765	-39%	-$138K	0.22%	159
2022 Q2	$325K	Buy	7,130 +2,205	+45%	+$98.6K	0.33%	108
2022 Q1	$229K	Buy	+4,925	New	+$220K	0.38%	95

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CAM

Congress Asset Management Boston, Massachusetts $16.3B AUM 42.69% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Riverwater Partners's LMAT Position: Q1 2026 in Review

Riverwater Partners increased its LeMaitre Vascular (LMAT) stake by 4.3% in Q1 2026, buying an estimated $86.5K and bringing the position to 22,271 shares worth $2.43M. The position accounts for 0.81% of the portfolio, ranked #40.

Riverwater Partners first reported a position in LMAT in Q1 2022 and has held it in 17 quarters since. The position peaked at $2.89M in Q3 2024. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

Riverwater Partners held 22,271 shares of LeMaitre Vascular worth $2.43M as of Q1 2026.
Riverwater Partners bought 908 LeMaitre Vascular shares in Q1 2026, an estimated $86.5K.
LeMaitre Vascular made up 0.81% of Riverwater Partners's portfolio in Q1 2026, its #40 holding.
Riverwater Partners first reported a position in LeMaitre Vascular in Q1 2022 and has held it in 17 quarters since.
Riverwater Partners's LeMaitre Vascular position peaked at $2.89M in Q3 2024.
339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Riverwater Partners's 13F filing for Q1 2026, filed 8 May 2026.